€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project Cambridge, UK, and Geneva, Switzerland: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out developing world-class viral and non-viral DNA delivery systems, have received a €1.6 million grant from Eurostars. The […]
Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing Multi-resistant bacterial sepsis infections to be validated utilising Symcel’s sensitive screening technology Symcel, the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™, has secured €3.572 million Horizon 2020 funding to support the company’s evaluation […]
Cambridge, UK Base4 Innovation Ltd, the biotechnology company specialising in single molecule DNA sequencing, closed an oversubscribed funding round last month, led by Longwall Ventures. The funding round, capped at £5 million, is the Company’s largest to date, with a total of £21.3 million raised since 2009. The funds will be used to expand the […]
The European Commission has appointed Phase Holographic Imaging, Bundesanstalt für Material-forschung und Prüfung (Germany’s federal technology research institute), Malmö, Umeå, Copenhagen and Turku University to develop improved methods for clinically diagnosing cancer. The €2.1 million grant finances a three-year research project which is coordinated by Malmö University and commercialized by Phase Holographic Imaging (PHI). Current methods for […]
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types Exclusive IP licensed from the University of Cambridge Geographically diversified, top-tier investor team includes key industry leaders to support early company development Cambridge, UK: Elpis BioMed, a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell […]
IsoPlexis will use four new NIH grants to advance research and development of immunotherapies to treat solid tumors, bone marrow disease, autoimmune diseases and infectious diseases. Branford, Conn.—IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology and the immune-based cancer treatment revolution, announced today that it has received […]
PARIS—Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces today the completion of its initial fundraising. A total of €1.2m has been obtained from two European seed funds: Paris, France-based Seventure Partners’ Quadrivium I seed fund and Bonn, Germany-based High-Tech […]
HOUSTON — Genialis, Inc., a leading provider of cloud software for the visual exploration of next generation sequencing data, recently closed a $2.3M Seed round. The financing will accelerate the team’s expansion in the U.S. and commercialization of Genialis Platform. Redalpine Venture Capital in Zurich and First Star Venture Capital in Boston co-led the round, joined by Slovenian firm Pikas d.o.o. Several expert […]
London – Management confirms that trading is in line with expectations, with good momentum continuing through the second half of the year to 31 March 2018. Key Highlights Acquisition of LINK Technologies LGC continued its expansion through targeted M&A, with the acquisition of LINK Technologies on 19 July 2017, strengthening its oligo reagents offering. LINK is a […]
America’s Seed Fund Powered by NSF Provides Funding for R&D; Helps small businesses move innovations out of the lab and into the market StabiLux Biosciences has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase II grant for $600,000 to commercialize innovative technology by conducting research and development (R&D) work on […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
